drug

volrustomig

1 story · latest Aug 17, 2026

Status: Investigational
Code: MEDI5752
Trials: 14 registered trials in coverage

Relationships

Developed by AstraZeneca

Timeline

AstraZeneca halts eVOLVE-Lung02 trial of volrustomig in lung cancer

Aug 17Clinical readoutAstraZeneca volrustomig

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.